富祥药业：2025年度业绩预告

Core Viewpoint - Fuxiang Pharmaceutical has announced its performance forecast for the year 2025, indicating a projected revenue decline compared to the previous year, along with expected losses in net profit [1] Group 1: Revenue Forecast - The company expects its operating revenue for 2025 to be between 1.15 billion and 1.25 billion yuan, compared to 1.17785 billion yuan in the same period last year [1] Group 2: Profit Forecast - The net profit attributable to shareholders is anticipated to be a loss ranging from 39 million to 57 million yuan, an improvement from a loss of 272.1 million yuan in the previous year [1]